31815636|t|URB597 protects against NLRP3 inflammasome activation by inhibiting autophagy dysfunction in a rat model of chronic cerebral hypoperfusion.
31815636|a|BACKGROUND: Previous studies reported that URB597 (URB) had therapeutic potential for treating chronic cerebral hypoperfusion (CCH)-induced neuroinflammation and autophagy dysfunction. However, the interaction mechanisms underlying the CCH-induced abnormal excessive autophagy and neuroinflammation remain unknown. In this study, we investigated the roles of impaired autophagy in nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing (NLRP) 3 inflammasome activation in the rat hippocampus and the underlying mechanisms under the condition of induced CCH as well as the effect of URB treatment. METHODS: The CCH rat model was established by bilateral common carotid artery occlusion (BCCAo), and rats were randomly divided into 11 groups as follows: (1) sham-operated, (2) BCCAo; (3) BCCAo+autophagy inhibitor 3-methyladenine (3-MA), (4) BCCAo+lysosome inhibitor chloroquine (CQ), (5) BCCAo+microglial activation inhibitor minocycline, (6) BCCAo+ROS scavenger N-acetylcysteine (NAC), (7) BCCAo+URB, (8) BCCAo+URB+3-MA, (9) BCCAo+URB+CQ, (10) BCCAo+URB+minocycline, (11) BCCAo+URB+NAC. The cell localizations of LC3, p62, LAMP1, TOM20 and NLRP3 were assessed by immunofluorescence staining. The levels of autophagy-related proteins (LC3, p62, LAMP1, BNIP3 and parkin), NLRP3 inflammasome-related proteins (NLRP3, CASP1 and IL-1beta), microglial marker (OX-42) and proinflammatory cytokines (iNOS and COX-2) were evaluated by western blotting, and proinflammatory cytokines (IL-1beta and TNF-a) were determined by ELISA. Reactive oxygen species (ROS) were assessed by dihydroethidium staining. The mitochondrial ultrastructural changes were examined by electron microscopy. RESULTS: CCH induced microglial overactivation and ROS accumulation, promoting the activation of the NLRP3 inflammasome and the release of IL-1beta. Blocked autophagy and mitophagy flux enhanced the activation of the NLRP3-CASP1 inflammasome pathway. However, URB alleviated impaired autophagy and mitophagy by decreasing mitochondrial ROS and microglial overactivation as well as restoring lysosomal function, which would further inhibit the activation of the NLRP3-CASP1 inflammasome pathway. CONCLUSION: These findings extended previous studies indicating the function of URB in the mitigation of chronic ischemic injury of the brain.
31815636	0	6	URB597	Chemical	MESH:C500528
31815636	24	29	NLRP3	Gene	287362
31815636	95	98	rat	Species	10116
31815636	108	138	chronic cerebral hypoperfusion	Disease	MESH:D006521
31815636	183	189	URB597	Chemical	MESH:C500528
31815636	191	194	URB	Chemical	MESH:C500528
31815636	235	265	chronic cerebral hypoperfusion	Disease	MESH:D006521
31815636	267	270	CCH	Disease	MESH:D006521
31815636	280	297	neuroinflammation	Disease	MESH:D000090862
31815636	376	379	CCH	Disease	MESH:D006521
31815636	421	438	neuroinflammation	Disease	MESH:D000090862
31815636	521	616	nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing (NLRP) 3	Gene	287362
31815636	648	651	rat	Species	10116
31815636	725	728	CCH	Disease	MESH:D006521
31815636	754	757	URB	Chemical	MESH:C500528
31815636	782	785	CCH	Disease	MESH:D006521
31815636	786	789	rat	Species	10116
31815636	825	856	common carotid artery occlusion	Disease	MESH:D002340
31815636	858	863	BCCAo	Disease	MESH:D002340
31815636	870	874	rats	Species	10116
31815636	947	952	BCCAo	Disease	MESH:D002340
31815636	958	963	BCCAo	Disease	MESH:D002340
31815636	984	999	3-methyladenine	Chemical	MESH:C025946
31815636	1001	1005	3-MA	Chemical	MESH:C025946
31815636	1012	1017	BCCAo	Disease	MESH:D002340
31815636	1037	1048	chloroquine	Chemical	MESH:D002738
31815636	1050	1052	CQ	Chemical	MESH:D002738
31815636	1059	1064	BCCAo	Disease	MESH:D002340
31815636	1097	1108	minocycline	Chemical	MESH:D008911
31815636	1114	1119	BCCAo	Disease	MESH:D002340
31815636	1120	1123	ROS	Chemical	MESH:D017382
31815636	1134	1150	N-acetylcysteine	Chemical	MESH:D000111
31815636	1152	1155	NAC	Chemical	MESH:D000111
31815636	1162	1167	BCCAo	Disease	MESH:D002340
31815636	1168	1171	URB	Chemical	MESH:C500528
31815636	1177	1182	BCCAo	Disease	MESH:D002340
31815636	1183	1186	URB	Chemical	MESH:C500528
31815636	1187	1191	3-MA	Chemical	MESH:C025946
31815636	1197	1202	BCCAo	Disease	MESH:D002340
31815636	1203	1206	URB	Chemical	MESH:C500528
31815636	1207	1209	CQ	Chemical	MESH:D002738
31815636	1216	1221	BCCAo	Disease	MESH:D002340
31815636	1222	1225	URB	Chemical	MESH:C500528
31815636	1226	1237	minocycline	Chemical	MESH:D008911
31815636	1244	1249	BCCAo	Disease	MESH:D002340
31815636	1250	1253	URB	Chemical	MESH:C500528
31815636	1254	1257	NAC	Chemical	MESH:D000111
31815636	1285	1288	LC3	Gene	25291
31815636	1290	1293	p62	Gene	117268
31815636	1295	1300	LAMP1	Gene	25328
31815636	1312	1317	NLRP3	Gene	287362
31815636	1406	1409	LC3	Gene	25291
31815636	1411	1414	p62	Gene	117268
31815636	1416	1421	LAMP1	Gene	25328
31815636	1423	1428	BNIP3	Gene	84480
31815636	1442	1447	NLRP3	Gene	287362
31815636	1479	1484	NLRP3	Gene	287362
31815636	1486	1491	CASP1	Gene	25166
31815636	1496	1504	IL-1beta	Gene	24494
31815636	1564	1568	iNOS	Gene	24599
31815636	1573	1578	COX-2	Gene	26198
31815636	1647	1655	IL-1beta	Gene	24494
31815636	1660	1665	TNF-a	Gene	24835
31815636	1693	1716	Reactive oxygen species	Chemical	MESH:D017382
31815636	1718	1721	ROS	Chemical	MESH:D017382
31815636	1740	1755	dihydroethidium	Chemical	MESH:C067883
31815636	1855	1858	CCH	Disease	MESH:D006521
31815636	1897	1900	ROS	Chemical	MESH:D017382
31815636	1947	1952	NLRP3	Gene	287362
31815636	1985	1993	IL-1beta	Gene	24494
31815636	2063	2068	NLRP3	Gene	287362
31815636	2069	2074	CASP1	Gene	25166
31815636	2106	2109	URB	Chemical	MESH:C500528
31815636	2182	2185	ROS	Chemical	MESH:D017382
31815636	2307	2312	NLRP3	Gene	287362
31815636	2313	2318	CASP1	Gene	25166
31815636	2421	2424	URB	Chemical	MESH:C500528
31815636	2454	2482	ischemic injury of the brain	Disease	MESH:D001930
31815636	Negative_Correlation	MESH:D000111	MESH:D017382
31815636	Positive_Correlation	MESH:D017382	24494
31815636	Negative_Correlation	MESH:C500528	MESH:D002340
31815636	Negative_Correlation	MESH:C500528	MESH:D000090862
31815636	Cotreatment	MESH:C500528	MESH:D000111
31815636	Association	25166	287362
31815636	Negative_Correlation	MESH:D000111	MESH:D002340
31815636	Negative_Correlation	MESH:C025946	MESH:D002340
31815636	Association	MESH:D006521	287362
31815636	Negative_Correlation	MESH:C500528	MESH:D006521
31815636	Cotreatment	MESH:C500528	MESH:D008911
31815636	Negative_Correlation	MESH:C500528	287362
31815636	Negative_Correlation	MESH:D008911	MESH:D002340
31815636	Negative_Correlation	MESH:C025946	MESH:C500528
31815636	Negative_Correlation	MESH:D002738	MESH:D002340
31815636	Negative_Correlation	MESH:C500528	MESH:D002738
31815636	Association	24494	287362

